PHILADELPHIA, PA (February 18, 2026) – Alumni of the Science Center’s Capital Readiness Program (CRP) have collectively raised $137 million, advancing healthcare innovation, creating jobs, and attracting investor interest from across the country. As the organization prepares to welcome its 10th cohort March 2-6, this milestone underscores the Science Center’s role in strengthening the capital layer of the healthcare innovation ecosystem.
As a core pillar of The Translation ProjectTM, the Science Center’s operating system for accelerating the translation of healthcare innovations into real-world solutions, CRP is designed for companies approaching a first institutional fundraising round, CRP equips founders with the network, insights, and practical skills needed to engage credibly and confidently with healthcare stakeholders.
Since 2023, the Capital Readiness Program has become a trusted growth platform for companies addressing cardiovascular health, aging and longevity, oncology, healthcare workflow and infrastructure, and more—reflected in the program’s strong outcomes. To date the Capital Readiness Program has achieved:
- 89 companies supported across the U.S., Canada, and UK
- $137 million* raised by CRP alumni companies with $33 million of that total by companies in Greater Philadelphia
- 173 jobs created
- 35 companies are generating revenue
- 35 investors engaged across the U.S. representing $1.35 billion in venture capital
“This milestone cohort reflects the durability of the Capital Readiness Program and the unmet demand for sophisticated, tactical startup support focused on derisking, building evidence, and accelerating the time to market,” said Tiffany Wilson. “As a foundational pillar of The Translation Project, CRP directly aligns with our broader strategy to accelerate healthcare innovation. We’re proud to support these companies at a time when healthcare innovation isn’t just an opportunity, it’s a necessity.”
“The Capital Readiness Program goes beyond a typical accelerator. It helped us generate the kind of evidence healthcare investors and stakeholders actually value, sharpen our strategy, and prepare for institutional capital with real confidence,” says Annika Lundström, CEO of ReMinded, Inc.
Capital Readiness Cohort 10:
AltruMed (Philadelphia, PA)
AltruMed develops wearable technology, rooted in clinical and public health expertise, to prevent accidental overdose deaths and support individual recovery journeys.
Band Connect (Cincinnati, OH)
Band Connect is a patented, evidence-based hybrid therapy platform that transforms orthopedic rehabilitation through objective performance data - improving patient outcomes and engagement while driving new revenue for clinics.
Cadense Inc. (Santa Barbara, CA)
Cadense is an adaptive footwear company that designs patented, research-backed shoes to help people with walking difficulties move more safely and confidently by combining smooth glide during motion with secure grip when it matters most.
HeyKiddo (Philadelphia, PA)
HeyKiddo is a mental health technology company that provides families with practical, science-based tools to build emotional resilience and confidence in children and the adults who support them.
Innovations Unlimited (Pennsauken, NJ)
Innovations Unlimited is a women-owned business whose mission is to develop products designed to enhance quality of life and reduce healthcare costs.
Kaizen Design (Kearney, NE)
Kaizen is the first platform for hospitals and health systems to manage and enforce building design standards - a problem that costs them 5-15% on every construction project through rework, delays and preventable mistakes.
Moberg Analytics, Inc. (Philadelphia, PA)
Moberg Analytics builds clinical software for critical care that helps detect and manage brain injury earlier and more precisely.
Pandora S9 Inc (DBA Diagnostics Your Way) (Philadelphia, PA)
End to end virtual diagnosis, testing and treatment for Sexual Health.
PDC Remote Care (Gadsden, AL)
PDC Remote Care connects patients and clinicians between visits using software and smart blood-pressure devices to improve hypertension outcomes and generate predictable, recurring revenue.
Wide Therapy (Philadelphia, PA)
Wide is an Augmented Ability Bridging Platform that helps Autistic children and adults master life skills they are not able to perform in reality by rehearsing them in noise reduced, personalized, digital environments.
The 10 companies will be joined by five investors who will spend the week working alongside the founders, offering them valuable access to the criteria behind investor thinking.
Cohort 10 Investors-in-Residence:
- Kwamena Aidoo, Managing Partner, Corridor Ventures (New Orleans, LA)
- Karlos Bledsoe, Principal, Seae Ventures (Chicago, IL)
- Chirag Goel, Principal, Propellant Ventures (Chicago, IL)
- Greg Howard, General Partner, Quorum Capital Partners (Philadelphia, PA)
- Maren Nelson, Co-Chair, Life Science Screening Committee, Alliance of Angels (Seattle, WA)
*While each company and investor is listed by home city, many of their teams operate remotely and/or source opportunities nationally.
The Capital Readiness Program is funded in part through a grant from the U.S. Small Business Administration and the U.S. Economic Development Administration (EDA), in addition to financial support from Cozen O’Conner. Following the cohort, CIC Labs + Innovation Campus will provide each company with a six-month membership to support continued growth and collaboration.
The program is free to selected participants. There is no pitch competition or demo-day — the focus is entirely on building investment readiness and strategic maturity.
Cohort 11 will take place April 27-May 1. Applications are currently being accepted for Cohort 12 scheduled for December 7-11, 2026.
Learn more and apply here: https://sciencecenter.org/programs/capital-readiness
*A total of $178 million has been raised by Science Center alumni since 2023
About the Science Center
The Science Center is a premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Recognized by The Brookings Institution as a top-tier investor, mentor, and economic development partner, the Science Center has supported hundreds of early- and growth-stage companies, driving a combined $7.8B in annual economic impact in Greater Philadelphia alone. Today, the organization works across the globe to accelerate the translation of health innovations into real-world solutions, while delivering nationally recognized STEM education to Philadelphia youth. For more information, visit sciencecenter.org.
